(Q44444339)

3 December 2017

title

ICAM-1 and beta(3) integrin immunoexpression in malignant melanoma cells: can they be used as additional predictors? (English)

1 reference

3 December 2017

ICAM‐1 and β3 integrin immunoexpression in malignant melanoma cells: can they be used as additional predictors? (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.T01-1-1110207.X

3 January 2024

author name string

Nikolaos Kavantzas

3

1 reference

3 December 2017

Sofia Tseleni-Balafouta

4

1 reference

3 December 2017

Georgia Thomopoulou

5

1 reference

3 December 2017

Kyriaki Aroni

6

1 reference

3 December 2017

Konstantinos N. Haritopoulos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752222

3 January 2024

Andreas C. Lazaris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752222

3 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12752222

3 January 2024

publication date

1 March 2003

1 reference

full work available at URL

3 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0463.2003.t01-1-1110207.x

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.T01-1-1110207.X

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1600-0463.2003.t01-1-1110207.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.T01-1-1110207.X

Acta Pathologica et Microbiologica Scandinavica

3 January 2024

published in

1 reference

3 December 2017

volume

111

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

421-429

1 reference

Tumor progression, early diagnosis and prognosis of melanoma

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110207.X

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110207.X

7 January 2021

Further validation of the prognostic model for stage I malignant melanoma based on tumor progression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110207.X

7 January 2021

Immunohistological examination of the relationship between metastatic potential and expression of adhesion molecules and 'selectins' on melanoma cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110207.X

7 January 2021

De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110207.X

7 January 2021

The impact of molecular biology on models for cell adhesion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110207.X

7 January 2021

Tumor progression in human malignant melanoma is associated with changes in α6/β1 laminin receptor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110207.X

7 January 2021

Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.T01-1-1110207.X

7 January 2021

Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells

14

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.T01-1-1110207.X

3 January 2024

Identifiers

1 reference

3 December 2017

1 reference